S. 5021 — 118th Congress
Federal bill
340B PATIENTS Act of 2024
- Title
- 340B PATIENTS Act of 2024
- Official title
- A bill to ensure the accessibility of drugs furnished through the drug discount program under section 340B of the Public Health Service Act.
- Type
- Senate bill
- Congress
- 118th Congress
- Chamber of origin
- Senate
- Introduced
- 2024-09-11
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Latest action date
- 2024-09-11
Organizations that named this bill in federal lobbying filings
- NYU LANGONE HOSPITALS (FORMERLY NYU HOSPITALS CENTER) Federal lobbying client (LDA)
- GSK (FKA GLAXOSMITHKLINE INC.) Federal lobbying client (LDA)
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA Federal lobbying client (LDA)
Federal lobbying filings naming this bill
U.S. Senate Lobbying Disclosure Act database. A filing names bills, issues and agencies — never the member lobbied — so these rows point only at the client organization, and none of them says any member of Congress was lobbied about this bill. The count is filings in this site's LDA slice, not the
- NYU LANGONE HOSPITALS (FORMERLY NYU HOSPITALS CENTER) cited in the filing's issue text 3 filings
- GSK (FKA GLAXOSMITHKLINE INC.) cited in the filing's issue text 2 filings
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA cited in the filing's issue text 2 filings